Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul;18(7):522-523.
doi: 10.1200/OP.22.00091. Epub 2022 Mar 21.

Breast Cancer Prevention and Breast Cancer Mortality

Rowan T Chlebowski  1 , Aaron K Aragaki  1 , Kathy Pan  1
Affiliations
Comment

Breast Cancer Prevention and Breast Cancer Mortality

Rowan T Chlebowski et al. JCO Oncol Pract. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Rowan T. Chlebowski

Honoraria: Novartis, AstraZeneca

Consulting or Advisory Role: Novartis, Genentech, Amgen, AstraZeneca, Immunomedics

Speakers' Bureau: Novartis, AstraZeneca

No other potential conflicts of interest were reported.

Comment on

  • Breast Cancer Prevention: Time for Change.
    Chlebowski RT, Aragaki AK, Pan K. Chlebowski RT, et al. JCO Oncol Pract. 2021 Dec;17(12):709-716. doi: 10.1200/OP.21.00343. Epub 2021 Jul 28. JCO Oncol Pract. 2021. PMID: 34319769 Free PMC article.
  • Breast Cancer Prevention Is Better Than Cure.
    Law RSL, Krupa K, Dowsett M, Rusby JE. Law RSL, et al. JCO Oncol Pract. 2022 Jul;18(7):521-523. doi: 10.1200/OP.22.00002. Epub 2022 Mar 21. JCO Oncol Pract. 2022. PMID: 35312351 No abstract available.

Similar articles

See all similar articles

Cited by

References

    1. Law R, Krupa K, Dowsett M, et al. Breast cancer prevention is better than cure JCO Oncol Practdoi: 10.1200/OP.22.00002 - DOI - PubMed
    1. Chlebowski RT, Aragaki AK, Pan K.Breast cancer prevention: Time for change JCO Oncol Pract 17709–7162021 - PMC - PubMed
    1. Chlebowski RT, Aragaki AK, Anderson GL, et al. Dietary modification and breast cancer mortality: Long-term follow-up of the Women's Health Initiative randomized trial J Clin Oncol 381419–14282020 - PMC - PubMed
    1. Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the Women's Health Initiative randomized clinical trials JAMA 324369–3802020 - PMC - PubMed
    1. Prentice RL, Aragaki AK, Chlebowski RT, et al. Randomized trial evaluation of the benefits and risks of menopausal hormone therapy among women 50–59 years of age Am J Epidemiol 190365–3752021 - PMC - PubMed